Lucis is a preventive health platform positioning itself as Europe's first preventive health Operating System. It analyzes blood test results across 60–180+ biomarkers to provide personalized, AI-powe
Lucis is a preventive health platform positioning itself as Europe's first preventive health Operating System. It analyzes blood test results across 60–180+ biomarkers to provide personalized, AI-powered health insights, biological age tracking, health scores, and actionable protocols reviewed by doctors. Founded in 2024/2025 and backed by Y Combinator (X25) and General Catalyst, Lucis serves customers across France, the UK, Ireland, and Portugal with a mission to make preventive health the default for every human in Europe.
Total raised
$9.0M
Last stage
Seed
Investors
Emilie Fidji Laplagne
Chief Marketing Officer at Lucis. Specific background details not publicly confirmed.
Maxime Berthelot
Repeat founder and biohacker who conducted personal n-of-1 experiments on biomarkers. Connected with co-founders through Paris longevity communities. Led Lucis from inception through YC X25 and $8.5M seed round.
LinkedInBaptiste Debever
Co-founder motivated by a relative's late medical diagnosis. Connected with Maxime Berthelot through Paris longevity communities. Repeat founder and technical operator. Announced Lucis publicly after 8 months of building.
LinkedInMax Guerois
Co-founder of Lucis, connected through Paris longevity communities. Repeat founder and biohacker.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.